VTRS peer analysis
Viatris (VTRS) against its competitors: price, today's move, 1-year return and market value side by side.
VTRS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALKS Alkermes | $46.01 | 3.30% | 51.00% | $7.67B |
| AMPH Amphastar Pharmaceuticals | $28.49 | 3.00% | 10.93% | $1.15B |
| AMRX Amneal | $20.40 | 4.88% | 75.77% | $7.04B |
| ANIP ANI Pharmaceuticals | $67.41 | -3.17% | -27.60% | $1.66B |
| BHC Bausch Health | $8.19 | 2.89% | 23.74% | $3.05B |
| HLN Haleon | $9.14 | -0.11% | -1.29% | – |
| OGN Organon | $13.86 | 0.51% | 112.12% | – |
| RDY Dr. Reddy's Laboratories | $14.82 | 2.00% | 10.50% | $11.91B |
| TEVA Teva | $42.75 | 2.32% | 102.88% | $48.88B |
| VTRS Viatris | $19.85 | 4.64% | 84.18% | – |
- VTRS's peers: ALKS (Alkermes), AMPH (Amphastar Pharmaceuticals), AMRX (Amneal), ANIP (ANI Pharmaceuticals), BHC (Bausch Health), HLN (Haleon), OGN (Organon), RDY (Dr. Reddy's Laboratories).
Updated 2026-11-07 11:56 UTC